<VariationArchive VariationID="1339651" VariationName="NM_001972.4(ELANE):c.574_583del (p.Gly192fs)" VariationType="Deletion" Accession="VCV001339651" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2022-02-12" MostRecentSubmission="2022-02-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1330817" VariationID="1339651">
      <GeneList>
        <Gene Symbol="ELANE" FullName="elastase, neutrophil expressed" GeneID="1991" HGNC_ID="HGNC:3309" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="852303" stop="856243" display_start="852303" display_stop="856243" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NT_187622.1" start="29537" stop="35129" display_start="29537" display_stop="35129" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="852290" stop="856245" display_start="852290" display_stop="856245" Strand="+" />
          </Location>
          <OMIM>130130</OMIM>
          <Haploinsufficiency last_evaluated="2022-07-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ELANE">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-07-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ELANE">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001972.4(ELANE):c.574_583del (p.Gly192fs)</Name>
      <CanonicalSPDI>NC_000019.10:855767:AGGGGCCGGCAGG:AGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="855768" stop="855777" display_start="855768" display_stop="855777" variantLength="10" positionVCF="855767" referenceAlleleVCF="GAGGGGCCGGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="855768" stop="855777" display_start="855768" display_stop="855777" variantLength="10" positionVCF="855767" referenceAlleleVCF="GAGGGGCCGGC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>G192fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.855771_855780del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.855771_855780del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.855771_855780del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.855771_855780del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007274.1" sequenceAccession="NG_007274" sequenceVersion="1" change="g.1107_1116del">
            <Expression>NG_007274.1:g.1107_1116del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009627.1" sequenceAccession="NG_009627" sequenceVersion="1" change="g.8481_8490del">
            <Expression>NG_009627.1:g.8481_8490del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001972.4" sequenceAccession="NM_001972" sequenceVersion="4" change="c.574_583del" MANESelect="true">
            <Expression>NM_001972.4:c.574_583del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001963.1" sequenceAccession="NP_001963" sequenceVersion="1" change="p.Gly192fs">
            <Expression>NP_001963.1:p.Gly192fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001972.4" sequenceAccession="NM_001972" sequenceVersion="4" change="c.574_583delGGCCGGCAGG" MANESelect="true">
            <Expression>NM_001972.4:c.574_583delGGCCGGCAGG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_46" sequenceAccession="LRG_46">
            <Expression>LRG_46:g.1107_1116del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_57" sequenceAccession="LRG_57">
            <Expression>LRG_57:g.8481_8490del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2145148969" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001972.4(ELANE):c.574_583del (p.Gly192fs) AND Neutropenia, severe congenital, 1, autosomal dominant" Accession="RCV001824553" Version="2">
        <ClassifiedConditionList TraitSetID="5486">
          <ClassifiedCondition DB="MedGen" ID="C1859966">Neutropenia, severe congenital, 1, autosomal dominant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-02-12" MostRecentSubmission="2022-02-12">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5486" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3464" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neutropenia, severe congenital, 1, autosomal dominant</ElementValue>
                <XRef ID="MONDO:0042490" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SCN1</ElementValue>
                <XRef Type="MIM" ID="202700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Severe Congenital Neutropenia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia. In congenital neutropenia, omphalitis immediately after birth may be the first sign; in untreated children diarrhea, pneumonia, and deep abscesses in the liver, lungs, and subcutaneous tissues are common in the first year of life. After 15 years with granulocyte colony-stimulating factor treatment, the risk of developing myelodysplasia (MDS) or acute myelogenous leukemia (AML) is approximately 15%-25%. Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts. Cellulitis, especially perianal cellulitis, is common during neutropenic periods. Between neutropenic periods, affected individuals are generally healthy. Symptoms improve in adulthood. Cyclic neutropenia is not associated with risk of malignancy or conversion to leukemia.</Attribute>
                <XRef ID="NBK1533" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ELANE-Related Neutropenia</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301705</ID>
                <ID Source="BookShelf">NBK1533</ID>
              </Citation>
              <XRef ID="C1859966" DB="MedGen" />
              <XRef ID="MONDO:0042490" DB="MONDO" />
              <XRef Type="MIM" ID="202700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4064876" SubmissionDate="2022-02-08" DateLastUpdated="2022-02-12" DateCreated="2022-02-12">
        <ClinVarSubmissionID localKey="MUCKK57|OMIM:202700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002074125" DateUpdated="2022-02-12" DateCreated="2022-02-12" Type="SCV" Version="1" SubmitterName="Genomics Facility, Ludwig-Maximilians-Universität München" OrgID="507363" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <GeographicOrigin>Middle East</GeographicOrigin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>4</NumberTested>
              <Gender>female</Gender>
              <FamilyData NumFamilies="1" NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <NamePlatform>NextSeq 500</NamePlatform>
              <TypePlatform>NGS</TypePlatform>
              <Description>Agilent V6 + UTR</Description>
              <Software name="BWA 0.7.15, GATK 3.6, VEP 89" />
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Whole Exome Sequencing; Sanger Sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001875" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELANE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001972.4:c.574_583delGGCCGGCAGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="202700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11050143</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4064876" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001875" MappingRef="HP">
        <MedGen CUI="C0853697" Name="Neutropenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4064876" TraitType="Disease" MappingType="XRef" MappingValue="202700" MappingRef="OMIM">
        <MedGen CUI="C1859966" Name="Neutropenia, severe congenital, 1, autosomal dominant" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

